Literature DB >> 28315272

Sigma Receptors and Substance Use Disorders.

Valentina Sabino1, Callum Hicks2, Pietro Cottone3.   

Abstract

Thanks to advances in neuroscience, addiction is now recognized as a chronic brain disease with genetic, developmental, and cultural components. Drugs of abuse, including alcohol, are able to produce significant neuroplastic changes responsible for the profound disturbances shown by drug addicted individuals. The current lack of efficacious pharmacological treatments for substance use disorders has encouraged the search for novel and more effective pharmacotherapies. Growing evidence strongly suggests that Sigma Receptors are involved in the addictive and neurotoxic properties of abused drugs, including cocaine , methamphetamine , and alcohol. The present chapter will review the current scientific knowledge on the role of the Sigma Receptor system in the effects of drugs and alcohol, and proposes that this receptor system may represent a novel therapeutic target for the treatment of substance use disorders and associated neurotoxicity.

Entities:  

Keywords:  Addiction; Alcohol OR Ethanol; Alcoholism; Cocaine; Drug abuse OR Abused drug; Methamphetamine; Psychostimulant; Withdrawal

Mesh:

Substances:

Year:  2017        PMID: 28315272      PMCID: PMC9536180          DOI: 10.1007/978-3-319-50174-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  175 in total

1.  Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.

Authors:  M S Cowen; A H Rezvani; B Jarrott; A J Lawrence
Journal:  Alcohol Clin Exp Res       Date:  1999-06       Impact factor: 3.455

2.  Ethanol potentiates and blocks NMDA-activated single-channel currents in rat hippocampal pyramidal cells.

Authors:  M T Lima-Landman; E X Albuquerque
Journal:  FEBS Lett       Date:  1989-04-10       Impact factor: 4.124

3.  Repeated methamphetamine-treatment alters brain sigma receptors.

Authors:  Y Itzhak
Journal:  Eur J Pharmacol       Date:  1993-01-12       Impact factor: 4.432

4.  Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

5.  Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient.

Authors:  Nalini Vadivelu; Sukanya Mitra; Alan David Kaye; Richard D Urman
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2014-03-18

6.  Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Luca Steardo; George F Koob; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

7.  Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.

Authors:  J M Saavedra; J Axelrod
Journal:  Science       Date:  1972-03-24       Impact factor: 47.728

8.  Acute myocardial infarction in young adults who abuse amphetamines.

Authors:  Arthur N Westover; Paul A Nakonezny; Robert W Haley
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

9.  Psychiatric symptoms in methamphetamine users.

Authors:  Joan E Zweben; Judith B Cohen; Darrell Christian; Gantt P Galloway; Michelle Salinardi; David Parent; Martin Iguchi
Journal:  Am J Addict       Date:  2004 Mar-Apr

Review 10.  Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.

Authors:  Rosario Moratalla; Amit Khairnar; Nicola Simola; Noelia Granado; Jose Ruben García-Montes; Pier Francesca Porceddu; Yousef Tizabi; Giulia Costa; Micaela Morelli
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

View more
  8 in total

1.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Authors:  Hideaki Yano; Alessandro Bonifazi; Min Xu; Daryl A Guthrie; Stephanie N Schneck; Ara M Abramyan; Andrew D Fant; W Conrad Hong; Amy H Newman; Lei Shi
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

2.  Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors.

Authors:  Luisa L Scott; James J Sahn; Antonio Ferragud; Rachel C Yen; Praveen N Satarasinghe; Michael D Wood; Timothy R Hodges; Ted Shi; Brooke A Prakash; Kaitlyn M Friese; Angela Shen; Valentina Sabino; Jonathan T Pierce; Stephen F Martin
Journal:  Neuropsychopharmacology       Date:  2018-04-20       Impact factor: 7.853

3.  A behavioral and pharmacological characterization of palatable diet alternation in mice.

Authors:  Catherine F Moore; Gabrielle S Schlain; Samantha Mancino; Valentina Sabino; Pietro Cottone
Journal:  Pharmacol Biochem Behav       Date:  2017-10-31       Impact factor: 3.533

Review 4.  Neuropharmacology of compulsive eating.

Authors:  Catherine F Moore; Julia I Panciera; Valentina Sabino; Pietro Cottone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

5.  Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis.

Authors:  Luz Romero; Enrique Portillo-Salido
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

6.  Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.

Authors:  Marta Valenza; Angelo Blasio; Alyssa DiLeo; Pietro Cottone; Valentina Sabino
Journal:  Pharmacol Biochem Behav       Date:  2020-03-20       Impact factor: 3.697

Review 7.  Neuroscience of Compulsive Eating Behavior.

Authors:  Catherine F Moore; Valentina Sabino; George F Koob; Pietro Cottone
Journal:  Front Neurosci       Date:  2017-08-24       Impact factor: 4.677

Review 8.  Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors.

Authors:  Luca Botticelli; Emanuela Micioni Di Bonaventura; Fabio Del Bello; Gianfabio Giorgioni; Alessandro Piergentili; Adele Romano; Wilma Quaglia; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura
Journal:  Nutrients       Date:  2020-07-30       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.